EUPRAXIA PHARMACEUTICALS INC. Operating Lease Right-of-Use Assets
EUPRAXIA PHARMACEUTICALS INC. (EPRX) had Operating Lease Right-of-Use Assets of $152.70 thousand as of 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-03-13
- 2025-12-31: Operating Lease, Right-of-Use Asset $152.70K.
- 2024-12-31: Operating Lease, Right-of-Use Asset $67.02K.
- 2023-12-31: Operating Lease, Right-of-Use Asset $46.66K.
- 2022-12-31: Operating Lease, Right-of-Use Asset $87.29K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-12-31 | $152.70K 40-F · filed 2026-03-13 |
| 2024-12-31 | $67.02K 40-F · filed 2026-03-13 |
| 2023-12-31 | $46.66K 40-F · filed 2026-03-13 |
| 2022-12-31 | $87.29K 40-F · filed 2025-03-20 |
| 2021-12-31 | $132.02K 40-F · filed 2024-04-01 |